Task: Answer the multiple-choice question.
Question: Which drug exhibits a -6.356% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a. c1ccc(Cn2ncc3c(N4CCN(C(c5ccccc5)c5ccccc5)CC4)ncnc32)cc1
b. COc1cccc(C2CC(c3ccc(Cl)cc3)n3nc(N)nc3N2)c1
c. Cc1cc(Br)ccc1NC(=O)CN1CCN(c2ccccn2)CC1
Answer: b. COc1cccc(C2CC(c3ccc(Cl)cc3)n3nc(N)nc3N2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1cccc(C2CC(c3ccc(Cl)cc3)n3nc(N)nc3N2)c1
COc1cccc(C2CC(c3ccc(Cl)cc3)n3nc(N)nc3N2)c1
7-(4-chlorophenyl)-5-(3-methoxyphenyl)-4,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine